Sign In
|
Register
|
About Burlingame
|
Contact Us
Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast
|
Traffic
Burlingame News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Burlingame Gas Prices
Ski And Snow Reports
Financial Markets
American
Bagels
Bakery
Barbecue
Brew Pubs
Chinese
Coffee Houses
Continental
Deli
Fast Food
Ice Cream / Frozen Yogurt
Indian
Italian
Japanese
Mexican
Pizza
Resort Restaurants
Sandwiches
Seafood
Steaks, Chops
Sushi
Thai
Wine
Bars and Lounges
Night Clubs
Museums
Family Fun
Arts & Culture
Parks
Annual Events
Accommodations
Bed and Breakfast
Hotel and Motel Management
Hotels & Resorts
Vacation Rentals
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Libraries
Museums
Theatres
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Attractions & Entertainment
Activities
Air Tours
Amusement & Water Parks
Auditoriums, Halls & Facilities
Biking
Bowling, Billiards & Video Games
Casinos & Gaming
Comedy Clubs
Events & Festivals
Fishing
Galleries
General Attractions
Golfing
Group Adventures
Horseback Riding
Hot Air Ballooning
Ice Rinks
Indoor Climbing
Indoor Kart Racing
Jeep & Hummer Tours
Movie Theatres
Museums
Parks & Preserves
Shells
Sightseeing
Target Shooting
Theatre
Ticket Sales
Tours
Train Rides
Zoos
ATV & Hummer Tours
Automotive
Auto Detail
Auto Rental
Car Washes
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Mobile Detail
Mobile Home Dealers
Motorcycles
Parts & Supplies
Radio & Alarm Systems
Repair & Service
Road Service
RV Dealers
Tires
Towing
Window Tinting and Repair
Beauty & Fitness
Barbers
Beauty Salons
Cosmetics
Dance Clubs & Studios
Fitness Equipment & Apparel
Fitness Programs
Health Clubs & Gyms
Health Food Products & Vitamins
Health Services & Home Health
Manicures
Massage
Nutrition
Personal Trainers
Piercing & Tattoo
Plastic Surgeons
Skin Treatment
Tanning Salons
Weight Loss
Yoga
Bike, Hike, Team Building
Business & Professional Services
Appraisers
Benefit & Pensions Plans
Billing Services
Bookkeeping Service
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Chambers of Commerce
Communications Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Courier, Delivery & Messenger Service
Credit Check & Collection Agencies
Data Processing Service
Employment Services, Placement & Agencies
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Equipment Rentals
Graphic Design & Art
Human Resource Services
Industrial
Internet Services
Marketing & Advertising Services
Media Services
Notary Services
Office Furniture, Equipment & Supplies
Office Machines & Service
Office Supplies
Payroll Services
Photography
Printing & Publishing
Public Relations & Publicity
Screen Printing
Security & Investigative Services
Shipping, Packaging & Postal Services
Signs & Banners
Staffing & Support Services
Trade Shows, Expos & Conventions
Translators & Interpreters
Video Production
Waste Management & Recycling
Commercial Contractors
Concierge & Lifestyle Services
Contractors
Air Conditioning
Architects
Building Contractors & Consultants
Concrete
Drywall, Plastering & Insulation
Electric
Fences and Gates
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Inspectors & Surveyors
Landscaping
Painting & Wallcovering
Patio and Pool Enclosures
Plumbing
Pools, Spas & Saunas
Roofing
Special Trade Contractors
Domestic Services
Child Care Services
House sitting
Housecleaning
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment
Employment Agencies
Find or Post a Job
Temporary Help & Employment Contractors
Event & Sport Tickets
Fashion by Runway Magazine
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Check Cashing & Money Orders
Debt & Credit Counseling
Debt Help
Debt Services
Escrow Services
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Identity Theft Services
Investments
Loans
Mortgage Lenders
Personal
Golf
Government
City & County Government
Federal Government
National Government
Political Organizations
Post Offices
State Government
Hair Salons
Health and Medicine
Alternative Medicine / Acupuncture
Animal Health
Chiropractors
Counseling
Dentistry
Dermatologists
Drug Stores & Pharmacies
Emergency Services
Eye Care
First Aid
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Medical Equipment & Supplies
Nutrition
Physical Therapist
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Air Conditioning
Appliances
Bed & Bath
Building Materials & Hardware
Cabinets, Racks & Shelves
Carpets & Rugs
Cleaning Supplies & Services
Closets
Contractors
Domestic Services
Doors, Windows & Drapery
Electric
Floor Coverings
Furniture
Garages
Glass
Handyman
Heating, Cooling & AC
Home Improvement Centers
Interior Design & Decorating
Kitchen
Lamps & Lighting
Lawn & Garden
Locksmiths
Lumber
Nurseries & Garden Centers
Painting & Wallcoverings
Patios & Decks
Pest Control
Plumbing
Pools, Spas & Saunas
Roofing & Siding
Safety & Security
Sewage & Septic Systems
Sprinklers
Tools
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Lake and Water Sports
Laser Hair Removal
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Agriculture
Audio & Visual
Building Materials
Computers, Electronics & Telecommunications
Electronic Equipment
Food & Beverage
Home & Garden
Industrial Supplies & Services
Machine Shops
Metal
Plastics
Textiles & Apparel
Media
Print Publications
Radio Stations
Television Stations
Meeting & Event Planning
Audio & Visual
Event Facilities
Exhibit Designers
Lodging
Meeting Planners
Party Rentals & Entertainment
Recreational Services
Tourist Attractions
Travel Arrangement & Services
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Outdoor Living & Spas
Personal Service
Barbers, Beauty Salons & Spas
Car Wash
Child Care
Dry Cleaning and Laundry
Shoe Repair
Tailors and Alterations
Tattoos & Body Piercing
Pets
Pet Boarding & Kennels
Pet Grooming
Pet Shops
Pet Supplies & Food - Retail
Veterinary Hospitals
Plastic Surgery
Aesthetic Surgeon
Plastic Surgeon
Real Estate
Appraisers
Assisted Living & Elder Care Service
Commercial
Condominiums
Developers
Mobile Home Parks
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Schools
Title Companies
Religion
Relocation
Movers
Storage
Restaurants
Afghan
American
Asian
Bagels
Bakery
Barbecue
Brazilian
Breakfast
Brew Pubs
Burgers
Cajun
Chinese
Coffee Houses
Continental
Cuban
Deli
Downtown San Jose Restaurants
Fast Food
Filipino
Fondue
French
Fusion
German
Greek
Hawaiian
Ice Cream / Frozen Yogurt
Indian
International
Italian
Japanese
Jewish
Korean
Latin American
Lebanese
Mediterranean
Mexican
Middle Eastern
Mongolian
Persian
Pizza
Resort Restaurants
Sandwiches
Seafood
Soul Food
Southwestern
Spanish
Sports Bars
Steaks, Chops
Sushi
Taiwanese
Tapas
Thai
Vegetarian
Vietnamese
Wine
Shopping
Accessories
Antiques
Auctions
Auto, Window Glass
Books
Bridal Shops
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Convenience Stores
Department Stores
Electronics
Flowers
Furniture
Gas Stations
Gifts & Specialty Shops
Grocery Stores
Health Food Stores
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Office Supplies & Service
Pharmacies
Rental Service Stores
Resale Shops
Shoe Stores
Shopping Centers & Malls
Smoke Shops
Sporting Goods
Thrift Stores
Tire Dealers
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Day Spas
Resort Spas
Sports & Recreation
Arenas and Venues
Associations & Clubs
Bicycles
Boat Dealers & Equipment
Boating
Bowling Alleys
Camping & Parks
Dance Clubs & Studios, Instruction
Docks & Marinas
Equestrian
Fishing, Fishing Charters and Tours
Fitness Equipment & Apparel
Golf Courses
Golf Equipment & Supplies
Gymnastics
Health Clubs
Hiking
Instruction
Martial Arts
Professional Sports Teams
Race Tracks
Recreation Facilities
Rentals
Skateboarding
Skating Rinks
Sporting Goods
Tennis
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Airlines & Airports
Attractions
Auto Rentals
Bus Lines & Charters
Cruises
Hotels & Resorts
Passport Services
RV Parks and Recreational Vehicles
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Bridal Shops
Cakes & Caterers
Ceremony & Reception Venues
Consultants & Planners
Entertainment
Favors & Gifts
Florists
Health & Beauty
Photographers & Videographers
Rentals
Transportation
Your Business Here
Apartments
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Burlingame
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Morphosys Ag ADR
(NQ:
MOR
)
17.51
UNCHANGED
Streaming Delayed Price
Updated: 9:58 AM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Morphosys Ag ADR
< Previous
1
2
3
4
Next >
MorphoSys Presents Latest Data from the Phase 2 MANIFEST Study Evaluating the Potential of Pelabresib in the Treatment of Myelofibrosis
December 12, 2021
MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis - Data presented during poster and oral sessions at the 63rd...
From
MorphoSys AG
Via
AccessWire
MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi(R)) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
December 11, 2021
- RE-MIND2 compared patient outcomes from pivotal L-MIND study with matched patient populations treated with NCCN/ESMO recommended therapies - Results from the retrospective cohort analysis indicate...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
Product Safety
MorphoSys and Incyte Announce Additional Real-World Evidence Results from RE-MIND2 Study of Tafasitamab (Monjuvi®) in Combination with Lenalidomide for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
December 11, 2021
From
Incyte
Via
Business Wire
Corporate Calendar 2022
November 29, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 29, 2021 / Corporate Calendar 2022 Dear Madam/Sir, Please note MorphoSys' financial reporting dates 2022 as follows: Publication of Interim Statement /...
From
MorphoSys AG
Via
AccessWire
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results
November 11, 2021
- Monjuvi U.S. net product sales of US$ 22.0 million (€ 18.6 million), 22% growth Q-Q - Ten abstracts, including two oral presentations, accepted at upcoming ASH - Pelabresib data for arm 3 of MANIFEST...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
MorphoSys Announces Departure of Roland Wandeler
November 09, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 9, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that Roland Wandeler, Ph.D., has decided to step down from his position as Chief Operating...
From
MorphoSys AG
Via
AccessWire
Exposures
Product Safety
MorphoSys Presents Interim Results from M-PLACE Study with Felzartamab during American Society of Nephrology Annual Meeting
November 04, 2021
Felzartamab has the potential to rapidly and substantially reduce anti-PLA2R antibody titers in patients with anti-PLA2R-positive membranous nephropathy PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November...
From
MorphoSys AG
Via
AccessWire
MorphoSys to Present MANIFEST and RE-MIND2 Data from Expanded Hematology-Oncology Portfolio at the 2021 American Society of Hematology (ASH) Annual Meeting
November 04, 2021
- Updates from MANIFEST phase 2 trial in patients with myelofibrosis, including clinical updates on JAK naïve patients treated with pelabresib in combination with ruxolitinib, including translational...
From
MorphoSys AG
Via
AccessWire
MorphoSys AG Announces Monjuvi(R) Sales for the First Nine Months and Third Quarter of 2021 and Invitation to the Upcoming Conference Call on November 11, 2021
November 02, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 2, 2021 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) today announces that revenues from product sales of Monjuvi (R) (tafasitamab-cxix) in the U.S. amount to €...
From
MorphoSys AG
Via
AccessWire
MorphoSys AG: First Patient Dosed in Phase 2 IGNAZ Study of Felzartamab in Patients with Immunoglobulin A Nephropathy
October 20, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 20, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that the first patient has been dosed in the Phase 2 IGNAZ clinical trial evaluating...
From
MorphoSys AG
Via
AccessWire
MorphoSys' Licensing Partner Roche Received Breakthrough Therapy Designation for Gantenerumab in Alzheimer's Disease
October 11, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 11, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that its licensing partner Roche received Breakthrough Therapy Designation by the U.S. Food...
From
MorphoSys AG
Via
AccessWire
Exposures
Product Safety
MorphoSys and Incyte Announce the European Commission Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
August 26, 2021
-The decision by the European Commission is based on data from the L-MIND study evaluating tafasitamab in combination with lenalidomide as a treatment for patients with relapsed or refractory DLBCL -...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
Incyte and MorphoSys Announce the European Commission Approval of Minjuvi® (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
August 26, 2021
From
Incyte
Via
Business Wire
MorphoSys' Partner Incyte Announced Development and Commercialization Agreement with InnoCare for Tafasitamab in Greater China
August 17, 2021
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / August 17, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR) announced today that Incyte, its development and commercialization partner for tafasitamab, entered into...
From
MorphoSys AG
Via
AccessWire
MorphoSys AG Reports Second Quarter and First Half 2021 Results
July 29, 2021
- Monjuvi U.S. net product sales of € 14.9 million (US$ 18.0 million), 16% growth Q-Q - MorphoSys announced and subsequently completed its acquisition of Constellation Pharmaceuticals - Announced and...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
MorphoSys AG to Update Financial Guidance for 2021 and Reduce Financial Liabilities
July 26, 2021
Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No 596/2014 PLANEGG/MUNICH, GERMANY / ACCESSWIRE / July 26, 2021 / MorphoSys AG (FSE:MOR; NASDAQ:MOR)...
From
MorphoSys AG
Via
AccessWire
Invitation to MorphoSys' Second Quarter and First Half 2021 Results Conference Call on July 29, 2021
July 21, 2021
PLANEGG, GERMANY and MUNICH, GERMANY / ACCESSWIRE / July 21, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR), a commercial-stage biopharmaceutical company and a leader in antibody and protein technologies,...
From
MorphoSys AG
Via
AccessWire
MorphoSys Concludes a US $100 Million Capital Increase to Implement the Purchase of 1,337,552 shares by Royalty Pharma
July 16, 2021
PLANEGG, GERMANY / ACCESSWIRE / July 16, 2021 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) ("MorphoSys") today announced that its Management Board, with the approval of the Supervisory Board, has passed a...
From
MorphoSys AG
Via
AccessWire
MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology
July 15, 2021
Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma PLANEGG / MUNICH, GERMANY / ACCESSWIRE / July 15, 2021 / MorphoSys AG...
From
MorphoSys AG
Via
AccessWire
Topics
Earnings
Exposures
Financial
Product Safety
MorphoSys Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Constellation Pharmaceuticals
July 01, 2021
MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / July 1, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys") today announced the expiration of the waiting period under the Hart-Scott-Rodino...
From
MorphoSys AG
Via
AccessWire
Exposures
Product Safety
MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
June 25, 2021
- If approved, tafasitamab in combination with lenalidomide would represent an important new therapeutic option for eligible DLBCL patients in the European Union - The positive opinion from the CHMP is...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
Product Safety
Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
June 25, 2021
From
Incyte
Via
Business Wire
MorphoSys Commences Cash Tender Offer for All Outstanding Shares of Constellation Pharmaceuticals
June 16, 2021
PLANEGG, GERMANY / ACCESSWIRE / June 16, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) ("MorphoSys") today announced that it is commencing a cash tender offer to purchase all outstanding shares of...
From
MorphoSys AG
Via
AccessWire
Exposures
Product Safety
MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL
June 04, 2021
Presentation will be available on demand as part of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting BOSTON, MA and WILMINGTON, DE / ACCESSWIRE / June 4, 2021 / MorphoSys US Inc., a...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
Product Safety
MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma
June 02, 2021
MUNICH, GERMANY and CAMBRIDGE, MA / ACCESSWIRE / June 2, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ("MorphoSys"), announces today that it has entered into a definitive agreement with Constellation...
From
MorphoSys AG
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
MorphoSys to Acquire Constellation Pharmaceuticals
June 02, 2021
From
MorphoSys AG
Via
Business Wire
MorphoSys To Participate in UBS Global Healthcare Conference
May 21, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 21, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that Jean-Paul Kress, M.D., the company's Chief Executive Officer, will participate in a...
From
MorphoSys AG
Via
AccessWire
MorphoSys to Present Data on Tafasitamab (Monjuvi(R)) at the 2021 ASCO Annual Meeting
May 19, 2021
PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 19, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that new data from the tafasitamab (Monjuvi(R)) development program will be presented at the...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
Product Safety
MorphoSys and Incyte Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-line Treatment for Diffuse Large B-Cell Lymphoma
May 11, 2021
PLANEGG/MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / May 11, 2021 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) and Incyte (NASDAQ:INCY) today announced that the first patient has been dosed in the pivotal...
From
MorphoSys AG
Via
AccessWire
Exposures
COVID-19
Product Safety
Incyte and MorphoSys Announce First Patient Dosed in Phase 3 frontMIND Study Evaluating Tafasitamab Combination as a First-Line Treatment for Diffuse Large B-Cell Lymphoma
May 11, 2021
From
Incyte
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Events
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.